As the Senior Director of Investor Relations (IR) will serve as the company’s primary IR lead in the United States, representing the company to institutional investors, and other stakeholders in the largest biopharma investment market globally. You will report in to and work closely with the Head of Investor Relations (based in Australia) to design and execute a proactive, best-in-class investor relations strategy aligned with the company’s global growth trajectory, therapeutic pipeline, and ASX listing obligations.

You will bring a deep understanding of capital markets, biopharma sector dynamics, and the ability to effectively communicate the company’s value proposition to sophisticated US-based investors while ensuring global messaging alignment.

Main Responsibilities and Accountabilities: Investor Engagement & Market Presence Serve as the primary US-based spokesperson for institutional investors, analysts, and other capital markets stakeholders. Build and maintain strong, trust-based relationships with key investors across the US, including biopharma-specialist funds, generalist funds, and crossover investors. Lead non-deal roadshows, conference participation, and investor events in North America, working closely with the Head of IR and executive leadership. Act as an early warning system on US investor sentiment, competitive positioning, and capital markets trends.

Investor Relations Strategy & Messaging Partner with the Head of IR to design and deliver the global investor relations strategy, tailoring it for US investor audiences. Ensure consistent messaging across all investor communications including earnings releases, investor presentations, Q&A briefings, and ESG reports. Translate complex scientific, regulatory, and commercial developments into clear, compelling investment narratives.

Financial and Market Communications Support 6 monthly earnings cycle: preparation of results materials, scripts, Q&A, and post-results investor follow-up in the US time zone. Drive analyst engagement: manage coverage initiation, consensus tracking, and respond to analyst queries. Develop high-impact investor day agendas, presentations, and senior leadership briefings for US investor events. Coordinate with Corporate Communications and Legal/Compliance on disclosure, ASX listing rule requirements. and support ADR Based engagement.

Capital Markets Intelligence & Benchmarking Monitor peer company performance, sector news flow, and relevant biopharma indices to contextualize investor conversations. Provide insights to the Executive Team and Board on investor sentiment, sector trends, valuation drivers, and competitive positioning. Develop and maintain US investor targeting frameworks to broaden and diversify the shareholder base.

Internal Stakeholder Management and Collaboration Partner with the CEO, CFO, and Head of IR to prepare senior leaders for investor meetings, conferences, and earnings calls. Work cross-functionally with Group Finance, R&D, Commercial & Medical, Company Secretary, and Legal to gather information, ensure disclosure accuracy, and create a two-way flow of market intelligence into the business. Collaborate with Sustainability/ESG teams to incorporate ESG performance and reporting as required Contribute to the any other projects as require from time to time.

Position Qualifications and Experience Requirements: Post-graduate qualification in relevant discipline essential. 10+ years of experience in Investor Relations, Equity Research, Corporate Development, or Investment Banking, with a strong focus on biopharma/pharma/healthcare. Deep understanding of US capital markets and institutional investor landscape. Track record of leading investor engagement programs and building long-term investor relationships. Exceptional financial literacy, including comfort with P&L, balance sheet, cash flow, and valuation modelling. Ability to distill complex scientific/regulatory information into clear investment narratives. Strong written, oral and storytelling communication skills, with executive presence and board-level influencing skills. This is a Hybrid position requiring 3 days a week onsite in KOP Preferred: Prior experience at a dual-listed or global biopharma company (ASX/NASDAQ or similar). Existing relationships with key US biopharma analysts and investors

Our Benefits We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.

About CSL CSL is a leading global biotechnology company with a dynamic portfolio of life-saving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives through innovation. Learn more about CSL .

We want CSL to reflect the world around us At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL

Do work that matters at CSL!